TECHNOLOGY TRANSFER ACTIVITIES. The parties have identified a series of technology transfer activities required to prepare for Intermediate and Product batch production by Hollister-Stier. The Technology Transfer Project activities listed ix Xxxxxxx XX.X. of this Exhibit will be completed prior to the manufacture of CTM batches of the Intermediate and Product.
TECHNOLOGY TRANSFER ACTIVITIES. ❖ 3M and Penn State have filed joint IP under past programs. Considering joint IP on new material composition for this work. Summary Slide ❖ Key early data indicates success in achieving performance metrics. Still catalyst layer work and cell conditions to optimize for meeting loading and durability targets. ❖ We have demonstrated 100s of hours of lifetime at 600 mA/cm2 with previous polyolefin membranes in a collaboration between Penn State and U. South Carolina. Working to solidify the lifetime testing on current membranes with lower catalyst loadings. ❖ Larger scale synthesis is underway and will enable more membrane coating studies and lifetime testing. ❖ Work underway to meet Year 1 Go/No-Go. 500h AEMFC operation at 600 mA/cm2. Cell voltage > 0.6V. M12/Q4 Go/No-Go Anode/Cathode feed gas: H2/O2; Cell T ≥ 60oC; Anode/Cathode pressure ≤ 1.5 atma
TECHNOLOGY TRANSFER ACTIVITIES. During the period commencing [***] days from the Effective Date, and, unless otherwise agreed by ARCHEMIX and MERCK, ending [***] months thereafter (the “Technology Transfer Term”), ARCHEMIX shall provide MERCK with the training, documentation and other information relating to the use of the SELEX Process Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. and the SELEX Technology set forth in the SELEX Technology Transfer Plan (the “Technology Transfer Activities”) solely for the purpose of enabling MERCK to conduct Target Validation Activities. Without limiting the generality of the foregoing, ARCHEMIX agrees to be available for consultation and advice upon MERCK’s reasonable request after the initial training period at the ARCHEMIX Facility set forth in the SELEX Technology Transfer Plan. MERCK shall pay ARCHEMIX the FTE Cost of all FTEs used by ARCHEMIX in performing Technology Transfer Activities and reimburse ARCHEMIX for the Third Party Costs incurred by ARCHEMIX in connection with its performance of the Technology Transfer Activities (the “Technology Transfer Costs”) as set forth in Section 6.4.1(a) and as described more fully in the SELEX Technology Transfer Plan.
TECHNOLOGY TRANSFER ACTIVITIES. In consideration of the performance by ARCHEMIX of the Technology Transfer Activities under the SELEX Technology Transfer Plan as described in Section 3.2, during each Calendar Quarter of the Technology Transfer Term, MERCK will pay ARCHEMIX the Technology Transfer Costs and the FTE Cost applicable to the Technology Transfer Activities conducted during such Calendar Quarter within [***] days of MERCK’s receipt of an invoice corresponding to such Calendar Quarter.
TECHNOLOGY TRANSFER ACTIVITIES. Transfer of all GMP documentation related to the manufacture, quality control assays and quality assurance of the Arcelis technology. • This would include MPs, STMs and SOPs for GMP processing • Training of Green Cross technical personnel at Argos Therapeutics in the RNA and cellular process • Multiple visits required to perform RNA and cellular training runs • Training of Green Cross technical personnel at Argos on the quality control assays • Multiple visits required to perform quality control assay training • Completion of all documentation, acquisition of reagents and provide information and expertise for upfitting of GMP labs by Green Cross • Perform initial feasibility runs at Green Cross with Argos personnel oversight • Perform [**] successful GMP engineering runs at Green Cross
TECHNOLOGY TRANSFER ACTIVITIES. In furtherance of NASA‘s policy objective of encouraging technology transfer, costs incurred in promoting and facilitating U.S. public and private sector technology transfer consistent with the requirements of this Contract shall be allowable.
TECHNOLOGY TRANSFER ACTIVITIES. Not less than five percent of the funds made available to carry out this subsection for any fiscal year shall be available to carry out tech- nology transfer activities.
TECHNOLOGY TRANSFER ACTIVITIES. NEMOSINE plans a technology transfer and training program to be carried out at the last stages of the project, between M30 and M48, which can include a balance of training in scientific and technological aspects directly related to the activities carried out within the scope of the project. Technology transfer and training program will target the wide range of production companies in the interest areas of the project e.g. new materials developed, sensors, modelling, etc and will include the following types of activities: Network-wide training. Access to a full range of different methodologies, tools and protocols being developed and applied by the NEMOSINE partners in the scope of the project activities, in an individual manner or collaboratively between two or more partners. This will be mainly done by the organization of two NEMOSINE workshops, that will be organized in M36 and M48, in parallel with the consortium meetings or a relevant external event and/or in collaboration with other R&D initiatives identified in Section 5 of this deliverable. The initial contents for the first workshop in M36 will be related to the progress achieved so far on the active acid adsorbers based on functionalized Metal Organic Framework (MOFs) integrated in low density and porous structures, and the gas detection sensors based on nanotechnology to monitoring AA, water, O2 & NO. However, these initial contents can be modified if the workshop in organized jointly with another initiative to complement any potential additional contents. Secondments. Exchange of researchers from one NEMOSINE partner organization to another is fostered in NEMOSINE for the execution of particular tasks related to the project activities. Also, technology transfer will be facilitated through the arrangement of ‘short stay’ training courses designed for scientists/technicians to take place at partner companies’ facilities to xxxxxx a quick transfer of the knowledge and technologies developed. Currently, joint PhD projects are coordinated by Xxx Xxxxx (NOVA) and Xxxxxxxx Xxxxxxxxx (CNRS): • Conservation and Valorisation of Xxxxxx xx Xxxxx Photographic and Filmic Collection (PhD researcher: Xxxxx Xxxxx) • Black and white: a study on the ageing and conservation of acetate and nitrate photographic negatives in Portuguese collections (PhD Researcher: Xxxx Xxxxxx) • The Books of Hours from the 15th century in the Portuguese collections: matter, form and meaning (PhD researcher: Xxxx Xxxxxx)
TECHNOLOGY TRANSFER ACTIVITIES. Transfer of all GMP documentation related to the manufacture, quality control assays and quality assurance of the Arcelis technology. o This would include MPs, STMs and SOPs for GMP processing · Training of China Company technical personnel at Argos Therapeutics in the RNA and cellular process o Multiple visits required to perform RNA and cellular training runs · Training of China Company technical personnel at Argos on the quality control assays o Multiple visits required to perform quality control assay training · Completion of all documentation, acquisition of reagents and provide information and expertise for upfitting of GMP labs by China Company · Perform initial feasibility runs at China Company with Argos personnel oversight · Perform three successful GMP engineering runs at China Company
TECHNOLOGY TRANSFER ACTIVITIES. Transfer of all GMP documentation related to the manufacture, quality control assays and quality assurance of the Arcelis technology. • This would include MPs, STMs and SOPs for GMP processing • Training of Pharmstandard technical personnel at Argos Therapeutics in the RNA and cellular process • Multiple visits required to perform RNA and cellular training runs • Training of Pharmstandard technical personnel at Argos on the quality control assays • Multiple visits required to perform quality control assay training • Completion of all documentation, acquisition of reagents and provide information and expertise for upfitting of GMP labs by Pharmstandard • Perform initial feasibility runs at Pharmstandard with Argos personnel oversight • Perform [**] successful GMP engineering runs at Pharmstandard
